Clinical trials: Mild to Moderate Dry Eye Disease
Dry Eye
Artificial Tears Study in Mild to Moderate Dry Eye Patients
The mean change in the subjective comfort score from baseline of the test group is at least 2.0 units less than that of the control group.
- Trial name
- NCT00607776
- Testing
- (9587X) Blink Tears, classified as an OTC Drug with the active ingredient being plyethylene glycol 400, Systane
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- Abbott Medical Optics
Dry Eye
A Study to Evaluate the Safety and Effectiveness Assessments of Restylane-Defyne for Punctual Occlusion
A study which participants with mild to moderate dry eye disease will have a punctum of one eye injected with 0.1ml Restylane Defyne and the other eye injected with 0.2ml Restylane Defyne.
- Trial name
- NCT04022382
- Testing
- Restylane Defyne
- Where
- United States
- Volunteers
- 17 people, healthy volunteers welcome
- Sponsor
- John C Meyer, MD
Dry Eye Syndrome
Cross-linked Hyaluronic Acid and Coenzyme Q10 in the Treatment of Dry Eye
Background: Dry eye disease (DED) is a common condition causing burden on visual function and reducing quality of life. Corticosteroids and/or cyclosporine eye drops are able to improve DED symptoms, however, side effects of…
- Trial name
- DEDCO (NCT03074344)
- Testing
- XLHA+CoQ10, Hyaluronic acid (HA)
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Azienda Ospedaliera Universitaria Policlinico "G. Martino"